Lixte Biotechnology Holdings Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -36.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -49.1% | +24.7% | -54.6% | +49.7% | -49.5% | -75.2% | +60.0% | -91.6% | +755.4% | +63.5% | +65.8% | +612.2% | -78.6% | -22.3% | +24.6% | +577.8% | -73.5% | +109.6% | -40.8% | -13.4% | +253.8% | -43.0% | -64.1% | +65.3% | +66.5% | -58.3% | +126.1% | -69.0% | +12.5% | -20.1% | +77.0% | +71.6% | -90.4% | +162.6% | -33.7% | -16.4% | +2.8% | +539.7% | -81.3% | – | |
| – | +60.6% | +16.2% | -12.7% | -7.1% | +27.8% | +7.5% | -7.1% | +213.5% | -63.0% | +2.3% | +40.3% | -4.6% | -60.1% | +40.2% | -12.7% | +214.1% | -16.8% | +92.1% | +14.7% | -31.3% | +20.9% | -2.1% | +15.5% | -12.7% | -2.2% | +0.2% | +5.2% | -28.2% | -1.7% | -3.3% | -5.8% | -22.1% | -6.9% | +6.4% | +16.0% | +145.1% | +1.2% | -6.7% | +38.3% | – | |
| – | -20.2% | +20.2% | -52.8% | +58.1% | -6.5% | -12.3% | -2.1% | +178.1% | -66.0% | +24.7% | +43.1% | +74.1% | -69.8% | +17.2% | -3.6% | +329.0% | -43.5% | +90.8% | +0.4% | -28.6% | +63.6% | -18.3% | -6.5% | -4.4% | +10.4% | -16.1% | +21.9% | -38.7% | +0.2% | -5.8% | +4.4% | -2.6% | -37.6% | +15.2% | +9.6% | +132.5% | +1.3% | +8.9% | +18.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -92.2% | +9.1% | +1,166.7% | +424.3% | -48.1% | +44.7% | -12.4% | -19.2% | +696.2% | +196.4% | +74.1% | -20.3% | -39.5% | -52.6% | -93.4% | -85.6% | +9,568.4% | -42.9% | -59.7% | -80.9% | +2,676.4% | -44.2% | -74.9% | +238.0% | +71.5% | +6.2% | -49.5% | -85.7% | +3,536.2% | -29.2% | -42.2% | -74.7% | +322.5% | -29.3% | -42.3% | -74.8% | +721.9% | -17.6% | -72.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,145,933.3% | – | – | – | -155.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -9,470.3% | – | – | – | – | – | – | -2,852,555.2% | – | – | – | -27,657.0% | – | – | – | -25,472.0% | – | – | – | +121.3% | -148,919.8% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.